NCT00307658|TerminatedPhase 3
Loading search results
Sponsor study identifier
interventional
40
1 country
2
Study Start
March 2001
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
July 2006
Date type not reportedThis date has not been verified as actual or estimated.
The aim of this study is to study the efficacy of intravenous immunoglobulins for inducing remission in patients relapsing of systemic vasculitides.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2006
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2001
Date type not reportedThis date has not been verified as actual or estimated.
March 27, 2006
Actual (reported)March 28, 2006
Actual (reported)July 2006
Date type not reportedThis date has not been verified as actual or estimated.
the remission rate after 9 months of therapy with intravenous immunoglobulins,
in relapsing patients with ANCA+ vasculitides (Microscopic Polyangiitis, Wegener's granulomatosis and Churg-Strauss syndrome)
during 6 months, after relapse
Safety, i.e. side-effects classified according to the WHO guidelines
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Hopital Cochin
Paris, 75679, France
Hôpital COCHIN
Paris, 75679, France
Martinez V, Cohen P, Pagnoux C, Vinzio S, Mahr A, Mouthon L, Sailler L, Delaunay C, Sadoun A, Guillevin L; French Vasculitis Study Group. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients. Arthritis Rheum. 2008 Jan;58(1):308-17. doi: 10.1002/art.23147.
Loïc GUILLEVIN, MD,PhD
Assistance Publique - Hôpitaux de Paris
First Submitted
March 27, 2006
First Posted
March 28, 2006
Study Start
March 2001
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
July 2006
Date type not reportedContact the study team to confirm eligibility.
This date has not been verified as actual or estimated.
Last Updated
May 22, 2006
Record last verified: 2003-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: